FWIW, AR was a very safe pair of hands at VXR and ultimately closed a deal with Bill Beament to create Develop (DVP). He's obviously seen something here at FXG he likes.
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status
